Abrocitinib vs Placebo or Dupilumab for Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Abrocitinib Versus Placebo or Dupilumab for Atopic Dermatitis
N. Engl. J. Med 2021 Mar 25;384(12)1101-1112, T Bieber, EL Simpson, JI Silverberg, D Thaçi, C Paul, AE Pink, Y Kataoka, CY Chu, M DiBonaventura, R Rojo, J Antinew, I Ionita, R Sinclair, S Forman, J Zdybski, P Biswas, B Malhotra, F Zhang, H Valdez, JADE COMPARE InvestigatorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.